Markets › United States › NAS › KRSA

Korsana Biosciences Inc

NAS:KRSAHealth Technologynasdaq_composite

$31.41−3.00%At closeAt close · Tue 20 Oct · ≈ AED 115.35 · Market cap $1.43B · Next earnings Tue 10 Nov

USD millions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Depreciation & amortization	2.3	0.5	0.1	0.0	—	—	—	—
Stock-based compensation	15.0	9.6	6.3	1.1	0.6	0.4	0.3	−27.0%
Operating cash flow	(72.5)	(36.5)	(40.6)	(21.2)	(4.3)	(3.3)	(4.5)	−34.3%
Capital expenditure	(1.5)	(0.0)	0.0	0.0	0.0	0.0	(0.1)	—
Dividends paid	—	—	—	0.0	0.0	0.0	0.0	—
Free cash flow	(74.0)	(36.5)	(40.6)	(21.2)	(4.3)	(3.3)	(4.5)	−36.3%